Foley Hoag Represents Organogenesis in Completed Merger with Avista Healthcare Public Acquisition Corp.
December 11, 2018
Foley Hoag LLP represented Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, in the completion of its merger with Avista Healthcare Public Acquisition Corp. (Nasdaq: AHPA), a publicly traded special purpose acquisition company.
Affiliates of Avista Capital Partners, a leading private equity firm, have invested $92 million in the combined company in conjunction with the transaction. Organogenesis’ management team, led by Gary S. Gillheeney, Sr., will run the combined company.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional senior level service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.